LAVA Therapeutics Q1 EPS $(0.02) Beats $(0.12) Estimate, Sales $6.99M Miss $7.00M Estimate
LAVA Therapeutics Q1 EPS $(0.02) Beats $(0.12) Estimate, Sales $6.99M Miss $7.00M Estimate
LAVA Therapeutics第一季度每股收益美元（0.02美元）超過預期（0.12美元），銷售額爲699萬美元，低於700萬美元的預期
LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.23 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $6.99 million which missed the analyst consensus estimate of $7.00 million by 0.11 percent. This is a 471.24 percent increase over sales of $1.22 million the same period last year.
LAVA Therapeutics（納斯達克股票代碼：LVTX）公佈的季度虧損爲每股0.02美元，比分析師共識估計的美元（0.12美元）高出83.33％。這比去年同期每股虧損0.53美元（0.53）增長了96.23％。該公司公佈的季度銷售額爲699萬美元，比分析師普遍預期的700萬美元低0.11％。這比去年同期的122萬美元銷售額增長了471.24％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。